C9orf72 and Cerebral cortical atrophy: To date, two longitudinal investigations have reported that there is no difference in the trajectory of cortical atrophy rates between asymptomatic C9orf72 mutation carriers and controls (22, 68), suggesting that longer time follow-up duration is needed to track the trajectory in asymptomatic C9orf72 mutation carriers (Table 3).